Back
Adaptimmune Therapeutics PLC Vs. TC BioPharm (Holdings) PLC Industry Stock Comparison
Sell
22
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.98
Seasonality Move:
-24.66%
Sell
19
TCBP
TC BioPharm (Holdings) PLC
Last Price:
5.32
Seasonality Move:
-70.73%
Sell
22
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.98. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
TC BioPharm (Holdings) PLC (TCBP)
is a Sell
Is TC BioPharm (Holdings) PLC a Buy, Sell or Hold?
- The current TC BioPharm (Holdings) PLC [TCBP] share price is $5.38. The Score for TCBP is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- TCBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight buying pressure.
TCBP Stock Price Chart
What is TC BioPharm (Holdings) PLC's stock price today?
-
The TC BioPharm (Holdings) PLC share price today is $5.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TCBP is experiencing slight selling pressure.
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 41.12 | Sell |
| Chaikin Money Flow: | 54046 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.99 - 1.21) | Sell |
| Bollinger Bands (100): | (0.98 - 1.22) | Sell |
TCBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 43.82 | Sell |
| Chaikin Money Flow: | -33710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.86 - 7.04) | Sell |
| Bollinger Bands (100): | (5.28 - 10.56) | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.97 | Buy |
| 20-day SMA: | 1.06 | Sell |
| 50-day SMA: | 1.13 | Sell |
| 200-day SMA: | 1.11 | Sell |
| 8-day EMA: | 0.98 | Sell |
| 20-day EMA: | 1.04 | Sell |
| 50-day EMA: | 1.09 | Sell |
| 200-day EMA: | 1.09 | Sell |
TCBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.11 | Sell |
| 20-day SMA: | 6.38 | Sell |
| 50-day SMA: | 5.81 | Sell |
| 200-day SMA: | 12.57 | Sell |
| 8-day EMA: | 6.01 | Sell |
| 20-day EMA: | 6.02 | Sell |
| 50-day EMA: | 6.43 | Sell |
| 200-day EMA: | 97.01 | Sell |
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
TC BioPharm (Holdings) PLC Earnings Growth & TCBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
TC BioPharm (Holdings) PLC Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||